Summary
As insurers continue to cover the Charite and other disc replacement products, the hope for coverage for other disc replacement technology will encourage further refinement and investment in motion preservation technology
Analysis
spine technologies such as cervical disc replacement, motion sparing devices, facet replacement technology, and other arthroplasty devices will face reimbursement challenges. CMS is placing the burden of proof on the manufacturers to show superiority against currently existing treatments. The expanded coverage for Charite will encourage companies such as DePuy, Medtronic, Nuvasive, and others to continue to pursue new technology.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
